Physician profile
David S Harper
NPI 1174550834
$1,245.75
in general payments reported to CMS, 2019-2025
16 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $73.31 · 2021: $54.51 · 2022: $82.68 · 2023: $250 · 2024: $140 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482 · Debt Forgiveness: $55.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.98 |
| Debt Forgiveness | $55.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $303.42 | 2019-2025 | Watchman Flx |
| Heartflow, INC. | $208.48 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.14 | 2019-2022 | |
| Medtronic, INC. | $156.80 | 2021-2023 | Micra |
| Pfizer INC. | $80.15 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $59.73 | 2019 | |
| Baxter Healthcare | $55.76 | 2023 | |
| Eisai INC. | $50.60 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $23.57 | 2022 | |
| Cvrx, INC. | $23.04 | 2024 | Barostim Neo System |
| Inspire Medical Systems, INC. | $22.93 | 2024 | Inspire |
| Novo Nordisk INC | $21.39 | 2023 | Rybelsus, Ozempic |
| Siemens Medical Solutions USA, INC. | $20.41 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $16.43 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $13.08 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.